ZYUS Life Sciences Corporation (TSXV:ZYUS)
Canada flag Canada · Delayed Price · Currency is CAD
0.7100
+0.0100 (1.43%)
Jul 3, 2025, 4:00 PM EDT

ZYUS Life Sciences Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
557063---
Market Cap Growth
-19.74%11.19%----
Enterprise Value
677765---
Last Close Price
0.710.940.90---
PS Ratio
114.48145.32179.10---
PB Ratio
-7.37-13.082.72---
P/TBV Ratio
--12.77---
EV/Sales Ratio
138.91161.10184.09---
Debt / Equity Ratio
-1.66-2.270.427.361.020.32
Asset Turnover
0.020.020.010.000.00-
Inventory Turnover
1.031.080.760.200.01-
Quick Ratio
0.080.130.490.030.111.35
Current Ratio
0.150.190.710.440.782.34
Return on Equity (ROE)
-546.27%-380.47%-305.81%-164.77%-67.78%-
Return on Assets (ROA)
-39.53%-35.05%-22.77%-15.46%-19.44%-
Return on Capital (ROIC)
-57.48%-49.66%-33.37%-23.08%-26.09%-
Earnings Yield
-62.52%-48.37%-67.75%---
FCF Yield
-17.79%-14.19%-29.00%---
Buyback Yield / Dilution
-13.62%-28.41%-45.82%24.99%-5.35%-
Updated Nov 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.